Syngene International's shares dropped 8.62% after lowering FY25 revenue guidance amid market challenges. Despite 10.5% YoY Q3 revenue growth and 17% profit rise, margins remain under pressure. Industry headwinds impact profitability, with flat profit growth expected ahead.